6I9I image
Entry Detail
PDB ID:
6I9I
Keywords:
Title:
Rift valley fever virus Gn in complex with a neutralizing antibody fragment
Biological Source:
PDB Version:
Deposition Date:
2018-11-23
Release Date:
2018-12-26
Method Details:
Experimental Method:
Resolution:
1.98 Å
R-Value Free:
0.24
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:RV-Gn1 Heavy chain
Chain IDs:A, E (auth: H)
Chain Length:223
Number of Molecules:2
Biological Source:Oryctolagus cuniculus
Polymer Type:polypeptide(L)
Description:RV-Gn1 Light chain
Chain IDs:B, F (auth: L)
Chain Length:217
Number of Molecules:2
Biological Source:Oryctolagus cuniculus
Polymer Type:polypeptide(L)
Description:Glycoprotein
Chain IDs:C, D
Chain Length:325
Number of Molecules:2
Biological Source:Rift valley fever virus
Primary Citation
A Protective Monoclonal Antibody Targets a Site of Vulnerability on the Surface of Rift Valley Fever Virus.
Cell Rep 25 3750 3758.e4 (2018)
PMID: 30590046 DOI: 10.1016/j.celrep.2018.12.001

Abstact

The Gn subcomponent of the Gn-Gc assembly that envelopes the human and animal pathogen, Rift Valley fever virus (RVFV), is a primary target of the neutralizing antibody response. To better understand the molecular basis for immune recognition, we raised a class of neutralizing monoclonal antibodies (nAbs) against RVFV Gn, which exhibited protective efficacy in a mouse infection model. Structural characterization revealed that these nAbs were directed to the membrane-distal domain of RVFV Gn and likely prevented virus entry into a host cell by blocking fusogenic rearrangements of the Gn-Gc lattice. Genome sequence analysis confirmed that this region of the RVFV Gn-Gc assembly was under selective pressure and constituted a site of vulnerability on the virion surface. These data provide a blueprint for the rational design of immunotherapeutics and vaccines capable of preventing RVFV infection and a model for understanding Ab-mediated neutralization of bunyaviruses more generally.

Legend

Protein

Chemical

Disease

Primary Citation of related structures